Activin ²B expression in rat experimental goiter and human thyroid tumors

Thyroid

Volumn 13, Issue 3, 2003, Pages 239-247

  Matsuo, Sílvia E ^a   Ebina, Kátia N ^a   Kulcsar, Marco A V ^a   Friguglietti, Celso U M ^a   Kimura, Edna T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; MESSENGER RNA; MYELOPID; PROTEIN SUBUNIT; THIAMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; NODULAR GOITER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID PAPILLARY CARCINOMA;

EID: 0037365468     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503321582033     Document Type: Article

References (45)

1. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R 1986 Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321:779-782.
2. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321:776-779.
3. Kingsley DM 1994 The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
4. Vale W, Hsueh A, Rivier C, Yu J 1991 The inhibin/activin family of hormones and growth factors. In: Sporn M, Roberts A (eds) Peptide Growth Factors and Their Receptors I. Springer-Verlag, New York, pp. 212-248.
5. Woodruff TK 1998 Regulation of cellular and system function by activin. Biochem Pharmacol 55:953-963.
6. Kimura ET, Kopp P, Zbaeren J, Asmis LM, Ruchti C, Maciel RM, Studer H 1999 Expression of transforming growth factor β1, β2, and β3 in multinodular goiters and differentiated thyroid carcinomas: A comparative study. Thyroid 9:119-125.
7. Wada M, Shintani Y, Kosaka M, Sano T, Hizawa K, Saito S 1996 Immunohistochemical localization of activin A and follistatin in human tissues. Endocr J 43:375-385.
8. Schulte KM, Jonas C, Krebs R, Roher HD 2001 Activin A and activin receptors in thyroid cancer. Thyroid 11:3-14.
9. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley A 1995 Functional analysis of activins during mammalian development. Nature 374:354-356.
10. Meunier H, Rivier C, Evans RM, Vale W 1988 Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 85:247-251.
11. Ogawa K, Abe K, Kurosawa N, Kurohmaru M, Sugino H, Takahashi M, Hayashi Y 1993 Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett 319:217-220.
12. Munro LM, Kennedy A, McNicol AM 1999 The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J Endocrinol 161:341-347.
13. Liu J, Heikkila P, Kahri AI, Voutilainen R 2000 Expression of activin A and its receptors in human pheochromocytomas. J Endocrinol 165:503-508.
14. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ 1997 Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
15. Colin IM, Nava E, Toussaint D, Maiter DM, vanDenhove MF, Luscher TF, Ketelslegers JM, Denef JF, Jameson JL 1995 Expression of nitric oxide synthase isoforms in the thyroid gland: Evidence for a role of nitric oxide in vascular control during goiter formation. Endocrinology 136:5283-5290.
16. Chen CC, Johnson PA 1996 Molecular cloning of inhibin/activin beta A-subunit complementary deoxyribonucleic acid and expression of inhibin/activin alpha- and beta A-subunits in the domestic hen. Biol Reprod 54:429-435.
17. LaPolt PS, Piquette GN, Soto D, Sincich C, Hsueh AJ 1990 Regulation of inhibin subunit messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinology 127:823-831.
18. Dykema JC, Mayo KE 1994 Two messenger ribonucleic acids encoding the common beta B-chain of inhibin and activin have distinct 5′-initiation sites and are differentially regulated in rat granulosa cells. Endocrinology 135:702-711.
19. Kotajima A, Miyamoto Y, Tsuruo M, Kosaka M, Saito S 1995 Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology 136:1214-1218.
20. Alexander JM, Swearingen B, Tindall GT, Klibanski A 1995 Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. J Clin Endocrinol Metab 80:147-152.
21. Yamashita K, Yamoto M, Shikone T, Minami S, Nakano R 1999 Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors. Am J Obstet Gynecol 180:316-322.
22. Mellor SL, Cranfield M, Ries R, Pedersen J, Cancilla B, de Kretser D, Groome NP, Mason AJ, Risbridger GP 2000 Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J Clin Endocrinol Metab 85:4851-4858.
23. Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F 1999 Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: Evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190-194.
24. Zhang YQ, Kanzaki M, Furukawa M, Shibata H, Ozeki M, Kojima I 1999 Involvement of Smad proteins in the differentiation of pancreatic AR42J cells induced by activin A. Diabetologia 42:719-727.
25. Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH 1989 Activin B: Precursor sequences, genomic structure and in vitro activities. Mol Endocrinol 3:1352-1358.
26. St-Onge L, Wehr R, Gruss P 1999 Pancreas development and diabetes. Curr Opin Genet Dev 9:295-300.
27. Harada K, Shintani Y, Sakamoto Y, Wakatsuki M, Shitsukawa K, Saito S 1996 Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metab 81:2125-2130.
28. Ying SY, Zhang Z, Furst B, Batres Y, Huang G, Li G 1997 Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 214:114-122.
29. Di Simone N, Crowley WF Jr, Wang QF, Sluss PM, Schneyer AL 1996 Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation. Endocrinology 137:486-494.
30. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ, Risbridger GP 1997 Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol 154:535-545.
31. Zauberman A, Oren M, Zipori D 1997 Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition. Oncogene 15:1705-1711.
32. Lin S, Ying SY 1999 Differentially expressed genes in activin-induced apoptotic LNCaP cells. Biochem Biophys Res Commun 257:187-192.
33. Chen W, Woodruff TK, Mayo KE 2000 Activin A-induced HepG2 liver cell apoptosis: Involvement of activin receptors and smad proteins. Endocrinology 141:1263-1272.
34. Franzen A, Piek E, Westermark B, ten Dijke P, Heldin NE 1999 Expression of transforming growth factor-betal, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 140:4300-4310.
35. Schulte KM, Jonas C, Krebs R, Roher HD 2000 Activin A and activin receptors in the human thyroid: A link to the female predominance of goiter? Horm Metab Res 32:390-400.
36. Matsuo SE, Magalhães MR, Woodruf TK, Kimura ET 1999 Characterization of activin A, activin B, and activin type IIB receptor in goiter and thyroid papillary carcinoma. 72nd Annual Meeting of the American Thyroid Association. Palm Beach-Florida, p. 25.
37. Massague J, Chen YG 2000 Controlling TGF-beta signaling. Genes Dev 14:627-644.
38. Pangas SA, Woodruff TK 2000 Activin signal transduction pathways. Trends Endocrinol Metab 11:309-314.
39. Heldin NE, Bergstrom D, Hermansson A, Bergenstrahle A, Nakao A, Westermark B, ten Dijke P 1999 Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells. Mol Cell Endocrinol 153:79-90.
40. Cerutti JM, Ebina KN, Maciel RMB, Kimura ET 2000 Expression of Smad4 and Smad 7, signaling mediators of TGFb superfamily, in thyroid follicular cell lines. 12th International Thyroid Congress Kyoto, Japan, P-401.
41. Morris III JC, Ranganathan G, Hay ID, Nelson RE, Jiang NS 1988 The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 123:1385-1394.
42. Asmis LM, Kaempf J, Von Gruenigen C, Kimura ET, Wagner HE, Studer H 1996 Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 (TGF-beta 1). J Endocrinol 149:485-496.
43. Ohta K, Pang XP, Berg L, Hershman JM 1996 Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab 81:2607-2612.
44. Gold LI 1999 The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10:303-360.
45. Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP 2000 Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell 11:1061-1076.